Treace Medical Concepts, Inc.
TMCI
$4.16
$0.102.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -10.22% | -9.01% | 11.37% | 6.60% | 2.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.22% | -9.01% | 11.37% | 6.60% | 2.86% |
| Cost of Revenue | -8.30% | -8.41% | 17.36% | 9.73% | 5.43% |
| Gross Profit | -10.71% | -9.15% | 9.89% | 5.82% | 2.23% |
| SG&A Expenses | -3.78% | 2.60% | 7.34% | -5.15% | -5.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.56% | -0.68% | 7.75% | -2.24% | -2.75% |
| Operating Income | -10.17% | -2,802.94% | 3.03% | 20.62% | 17.85% |
| Income Before Tax | -12.81% | -1,775.05% | -6.04% | 17.96% | 14.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.81% | -1,775.05% | -6.04% | 17.96% | 14.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.81% | -1,775.05% | -6.04% | 17.96% | 14.75% |
| EBIT | -10.17% | -2,802.94% | 3.03% | 20.62% | 17.85% |
| EBITDA | -23.98% | -498.26% | 8.31% | 25.27% | 23.08% |
| EPS Basic | -9.45% | -1,738.75% | -3.89% | 19.17% | 15.92% |
| Normalized Basic EPS | -9.45% | -1,204.00% | 2.53% | 19.16% | 15.93% |
| EPS Diluted | -10.19% | -1,287.74% | -3.89% | 19.17% | 15.92% |
| Normalized Diluted EPS | -9.45% | -1,204.00% | 2.53% | 19.16% | 15.93% |
| Average Basic Shares Outstanding | 3.08% | 2.44% | 2.07% | 1.49% | 1.41% |
| Average Diluted Shares Outstanding | 3.08% | 2.44% | 2.07% | 1.49% | 1.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |